TB-500 vs GHK-Cu (Copper Peptide)

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

TB-500

Thymosin Beta-4 (TB-500) is a naturally occurring peptide present in almost all human and animal cells. It plays a crucial role in tissue repair and regeneration.

Full details →

GHK-Cu (Copper Peptide)

GHK-Cu is a naturally occurring copper peptide found in human plasma, saliva, and urine. It plays important roles in wound healing, tissue repair, and has shown anti-aging properties in research.

Full details →

Side-by-Side Comparison

AspectTB-500GHK-Cu (Copper Peptide)
MechanismTB-500 promotes cell migration and differentiation, regulates actin (a cell-building protein), and reduces inflammation. It supports the formation of new blood vessels and wound healing.Attracts immune cells and fibroblasts to wound sites, stimulates collagen and glycosaminoglycan synthesis, promotes angiogenesis, and has antioxidant effects. Modulates gene expression related to tissue repair.
Typical DosageResearch protocols typically use 2-2.5mg twice weekly during the loading phase, followed by maintenance dosing of 2mg every 2 weeks.Topical: Applied as serum or cream 1-2 times daily. Injectable: 1-2mg daily for research purposes. Microneedling protocols often use 0.5-1%.
AdministrationAdministered via subcutaneous or intramuscular injection. Some protocols suggest injection near injury sites.Most commonly used topically for skin applications. Can be injected subcutaneously for systemic effects. Often combined with microneedling for enhanced skin penetration.
Side EffectsMay cause temporary fatigue, headache, or localized irritation at injection sites.Topical use is generally well-tolerated. May cause temporary skin irritation or redness in sensitive individuals. Injectable use may cause injection site reactions.
Best For

What They Have in Common

Both TB-500 and GHK-Cu (Copper Peptide) are commonly used for:

Key Differences

Unique to TB-500:

Unique to GHK-Cu (Copper Peptide):

Ready to Learn More?